Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).
about
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingNanoparticles for brain drug deliveryThe Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to BrainSystemic delivery to central nervous system by engineered PLGA nanoparticlesEnabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesPathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriersNanoscale drug delivery systems and the blood-brain barrierQuantitative analysis of nanoparticle transport through in vitro blood-brain barrier modelsUptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier modelLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancementsTargeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study.Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies.Bionanotechnology and the future of glioma.Conjugation of functionalized SPIONs with transferrin for targeting and imaging brain glial tumors in rat modelCombinatorial approaches for the identification of brain drug delivery targets.Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation.Identification of peptide sequences that target to the brain using in vivo phage display.OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.Co-opting biology to deliver drugsMinimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.Human serum albumin-based nanoparticle-mediated in vitro gene deliveryTransferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors.Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayersIn vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain.Nanoparticle-based technologies for retinal gene therapySynthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid.In vitro and in vivo brain-targeting chemo-photothermal therapy using graphene oxide conjugated with transferrin for Gliomas.Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastomaNano-enabled delivery of diverse payloads across complex biological barriers.Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivoTight junction modulation of the blood brain barrier: CNS delivery of small moleculesTherapeutic nanomedicine for brain cancer.Layered double hydroxide nanoparticles in gene and drug delivery.Cell-based in vitro blood-brain barrier model can rapidly evaluate nanoparticles' brain permeability in association with particle size and surface modificationIn vivo methods to study uptake of nanoparticles into the brain.Nanoparticulate systems for drug delivery and targeting to the central nervous system.Antibody-targeted nanoparticles for cancer therapy.
P2860
Q21223671-757BE2C7-ECE1-4A9A-A3BC-35D01308B4B7Q21285117-B0B628BC-EE08-4541-906D-AE4C717445D8Q26745586-49CF43FC-09E7-4A05-8364-53C469888F31Q26751294-9D483DF0-2F1C-4DB0-A0ED-3C42A27D51B7Q26850868-D9F7FF65-C5B4-473E-BD74-132C0861B0E4Q26852773-CFA21B5B-CA45-4671-AB4D-7F66088191D9Q27026978-5D59FADF-DE57-40EF-B9D5-079EB6BAFD8CQ28392542-B58E550B-8F67-404F-9EDE-DFDE4E7C9873Q28481345-B91ABD8C-A246-4510-85BF-56A1FF2A5760Q30366990-D72BBADE-C225-4372-9BA6-84D28F775CE3Q30393215-C6A9BF49-19EB-4CC5-8BF7-EA8F0A67B154Q30406070-719DB135-C913-4BBE-8187-C75C470A1E4AQ30409983-8841456F-5508-4359-B4E2-7B415E182429Q30417964-EE328F66-3D28-4EFD-AA7D-E87C64D3E9D7Q31061973-88399158-534A-48FA-8034-6089F08326DDQ31119779-6F0DB6B0-B755-44A1-A98D-318C2D1D9B15Q33622573-0A9F4CED-F488-4A2A-B21F-81D055C44C1DQ33776038-7623EB95-4508-4F3D-9065-5CCCF2148D58Q33972613-4F02A505-C50B-4128-BE0E-D8FE0DA4F3FFQ34062691-5D48FA2D-3F6B-44B4-A2F5-9597DAEDA389Q34165809-1BE2E364-C788-4719-BAD7-E56B73978519Q34424045-006602AA-7CBA-4488-805C-6FEFA24A784AQ34785621-8DA87E11-BF71-4387-B12A-45B32A64A170Q35258046-34A3868F-6908-49DC-8BE5-462078A25ED8Q35624123-5675E231-F6AD-4B26-A361-E4738A44DC01Q35636332-1B22892F-B1AA-4098-A532-3497AF47F923Q35797531-5B09E8D2-5866-4CEB-90DF-8E344492F4BEQ35843512-71FF61D6-B4DA-4388-89F4-12949BDC69E3Q36015949-06218A47-0958-49AF-9D77-0F5157C67D24Q36020442-C68538C6-9322-4436-A27C-0ACE8C6C71B6Q36145632-7E120915-099E-4FA2-A455-C4C9DF5E949AQ36307467-32A458EC-D389-4BAD-A5D7-C4161A1FFA4DQ36652635-BF0D7C9B-55C9-4206-BEFD-84CBE3591194Q36812411-5D800135-7F13-46EB-B47C-540013274C04Q37338427-14EE120E-4C90-4D80-AF50-E4E35BFCD0E3Q37580918-98C28F22-1330-4B05-BC72-66DF188967BEQ37645105-1371ECA7-BF85-4AF3-9C48-22A5F0DFBA84Q37798178-CBE69F92-A5B3-4D54-8BB5-97CBDA3D2E98Q37800505-6C77FAE2-6D6F-4914-9C6B-A88DE246972AQ37851969-E2B5D3D5-A2D7-4699-83A1-DC97C0D1FFAF
P2860
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Transferrin- and transferrin-r ...... the blood-brain barrier (BBB).
@en
Transferrin- and transferrin-r ...... across the blood-brain barrier
@nl
type
label
Transferrin- and transferrin-r ...... the blood-brain barrier (BBB).
@en
Transferrin- and transferrin-r ...... across the blood-brain barrier
@nl
prefLabel
Transferrin- and transferrin-r ...... the blood-brain barrier (BBB).
@en
Transferrin- and transferrin-r ...... across the blood-brain barrier
@nl
P2093
P921
P1476
Transferrin- and transferrin-r ...... the blood-brain barrier (BBB).
@en
P2093
Elisabeth Herbert
Jörg Kreuter
Karsten Ulbrich
Telli Hekmatara
P304
P356
10.1016/J.EJPB.2008.08.021
P407
P577
2008-09-05T00:00:00Z